| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.45 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |